💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Accelerate Diagnostics, Inc. (AXDX)
« Back to company indexAXDX Chatter Timeline
Stock Ticker for AXDX
Most Active Tweeters for AXDX
| User | Tweets |
|---|---|
| @Tickeron | 9 |
| @ResearchPool | 8 |
| @PennySearch | 4 |
| @newsfilterio | 4 |
| @FlashAlert_me | 3 |
Recent Tweets for AXDX
 |
@ChartMill $AXDX shows a strong growth in EPS: 14.38%, which is quite good. https://t.co/fDJL0FzaUI https://t.co/7bfI1sQukH January 25th 2022, 1:01am |
 |
@PennySearch $AXDX BTIG gave AXDX a Neutral stock rating on 2020-10-08. Find top penny stocks with PennySearch before the moo… https://t.co/1c1uCsgUkb January 24th 2022, 10:01pm |
 |
@ResearchPool $AXDX #ACCELERATE DIAGNOSTICS INC ... InsiderInsights Weekly Tables: January 22, 2022: InsiderInsights Ratings of C… https://t.co/UKZdubYkGp January 23rd 2022, 9:01pm |
|
@ResearchPool $AXDX #ACCELERATE DIAGNOSTICS INC ... InsiderInsights Daily Ratings Report: January 20, 2022: InsiderInsights Ratin… https://t.co/BDGLNJuXQE January 23rd 2022, 9:01pm |
|
@PennySearch $AXDX BTIG gave AXDX a Neutral stock rating on 2020-10-08. Find top penny stocks with PennySearch before the moo… https://t.co/SVmJqqmyIi January 22nd 2022, 5:01am |
 |
@newsfilterio $165,133.28 of shares acquired by Schuler Jack W (Director), reported in a new form 4 filed with the SEC $AXDX https://t.co/Nw2NikbR8q January 22nd 2022, 2:01am |
 |
@wallstreetmover $AXDX Showing Recent Insider Activity. See which insider was Bought $7.2M worth of shares in the last 3 months.… https://t.co/0lxwv85yOV January 21st 2022, 7:01pm |
 |
@InsiderAlerts4U $AXDX: New Insider Filing on Accelerate Diagnostics, Inc's 10%+ Owner SCHULER JACK W: https://t.co/z0ZMGwdPZ3 January 21st 2022, 9:01am |
 |
@Tickeron $AXDX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/u3YcCLaDtn January 21st 2022, 6:01am |
 |
@InsiderPurchase $AXDX - Accelerate Diagnostics, Inc #AccelerateDiagnostics Schuler Jack W (Dir, 10%) purchases +41,912 shares for $… https://t.co/6F2pfPc7Kc January 21st 2022, 6:01am |
|
@Tickeron $AXDX in -7.78% Downtrend, sliding for three consecutive days on January 13, 2022. View odds for this and other ind… https://t.co/XL2c7v5Ps3 January 21st 2022, 2:01am |
 |
@aistockfinder $AXDX https://t.co/JM2SBR7wQT Accelerate Diagnostics Inc. Our predictive algorithm has predicted the market value o… https://t.co/DKvew0crJD January 20th 2022, 9:01pm |
 |
@InsiderForms $AXDX Insider SCHULER JACK W has Purchased 41,912 Shares. Title :Director; 10% Owner Total Cost: $165,133.28 Buy/Se… https://t.co/CQRhxfxMwr January 20th 2022, 9:01pm |
 |
@FlashAlert_me $AXDX [15s. delayed] filed SEC form 4: Director SCHULER JACK W: Acquired 41,912 of Common Stock at price $3.94 on… https://t.co/iY3Dw1QmWw January 20th 2022, 9:01pm |
 |
@formwhisperscom #FWBuys $AXDX SCHULER JACK W, 10%-owner,Director of Accelerate Diagnostics, Inc bought 41,912 shares on 2022-01-18. https://t.co/McEqp5dHrp January 20th 2022, 9:01pm |
|
@Tickeron $AXDX enters a Downtrend because Momentum Indicator dropped below the 0 level on January 5, 2022. View odds for thi… https://t.co/6PNbUERSM5 January 20th 2022, 10:01am |
|
@PennySearch $AXDX BTIG gave AXDX a Neutral stock rating on 2020-10-08. Find top penny stocks with PennySearch before the moo… https://t.co/ZYLw7PX5GK January 20th 2022, 3:01am |
|
@ResearchPool $AXDX #ACCELERATE DIAGNOSTICS INC ... InsiderInsights Daily Ratings Report: January 18, 2022: InsiderInsights Ratin… https://t.co/gQwfs0haXJ January 19th 2022, 1:01pm |
 |
@bthefirsttoknow First out// $AXDX: 5 Penny Stocks Insiders Are Buying https://t.co/XIGzcxideA January 19th 2022, 1:01pm |
|
@InsiderPurchase $AXDX - Accelerate Diagnostics, Inc #AccelerateDiagnostics Schuler Jack W (Dir, 10%) purchases +131,219 shares for… https://t.co/cNZc8Tvsnv January 19th 2022, 8:01am |
 |
@kyzrrtrades $AXDX Interesting insider buys. https://t.co/XSmvUOrhZl January 19th 2022, 12:01am |
|
@Tickeron $AXDX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/ZLIGxnyw7y January 18th 2022, 10:01am |
|
@PennySearch $AXDX BTIG gave AXDX a Neutral stock rating on 2020-10-08. Find top penny stocks with PennySearch before the moo… https://t.co/FofX84vJ0W January 14th 2022, 7:01pm |
|
@Tickeron $AXDX in -7.78% Downtrend, sliding for three consecutive days on January 13, 2022. View odds for this and other ind… https://t.co/IjnWKFfsQ1 January 14th 2022, 8:01am |
|
@Tickeron This is why Hedge Funds use A.I. $AXDX price may climb as it broke lower Bollinger Band. #AccelerateDiagnostics… https://t.co/l2JZ113Ghg January 14th 2022, 8:01am |
|
@Tickeron Is this good for your portfolio? $AXDX RSI Indicator left the oversold zone. #AccelerateDiagnostics #stockmarket… https://t.co/jCyOuCpqpj January 14th 2022, 7:01am |
|
@Tickeron $AXDX in -4.69% Downtrend, sliding for three consecutive days on January 12, 2022. View odds for this and other ind… https://t.co/zkOH5Sw0Pa January 14th 2022, 12:01am |
|
@newsfilterio Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results $AXDX https://t.co/0QrtDy7hKj January 13th 2022, 7:01pm |
 |
@FynitiIQ $AXDX - Accelerate Diagnostics slips 3% as prelim 4Q FY21 revenue expected to be below consensus January 13th 2022, 4:01pm |
 |
@blackjackblack $AXDX jack needs to buy a lot more January 13th 2022, 3:01pm |
 |
@mehabecapital $AXDX @ 4.02 (-5.50%) : Accelerate Diagnostics slips 3% as prelim 4Q FY21 revenue expected to be below consensus https://t.co/LIAU8Xh73o January 13th 2022, 2:01pm |
 |
@MarketCurrents $AXDX - Accelerate Diagnostics slips 3% as prelim 4Q FY21 revenue expected to be below consensus https://t.co/y6kaMsKSxq January 13th 2022, 2:01pm |
|
@FlashAlert_me $AXDX [15s. delayed]: Issued Press Release on January 13, 09:15:00: Accelerate Diagnostics Announces Preliminary Fo… https://t.co/TDPWVpI1tG January 13th 2022, 2:01pm |
 |
@investor_feed $AXDX 8-K Accelerate Diagnostics (13 Jan, 9:16am) ? Accelerate Diagnostics Announces Preliminary Fourth Quarte… https://t.co/esa83UjmnL January 13th 2022, 2:01pm |
 |
@Market_Newswire $AXDX SEC Filing: 8-K Earnings Reg FD - Accelerate Diagnostics, Inc (0000727207) January 13 https://t.co/QdeyZALZOq January 13th 2022, 2:01pm |
 |
@StockNewsBot2 $AXDX Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results https://t.co/zdq6KAqCu3 January 13th 2022, 2:01pm |
 |
@stock_titan $AXDX Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results https://t.co/HvCD7C6kGH January 13th 2022, 2:01pm |
|
@InsiderPurchase $AXDX - Accelerate Diagnostics, Inc #AccelerateDiagnostics Schuler Jack W (Dir, 10%) purchases +45,226 shares for $… https://t.co/4y2uzNWovC January 13th 2022, 8:01am |
|
@Tickeron $AXDX in -3.96% Downtrend, falling for three consecutive days on January 11, 2022. View odds for this and other ind… https://t.co/LYpQiafJh9 January 13th 2022, 4:01am |
|
@newsfilterio $196,280.84 of shares acquired by Schuler Jack W (Director), reported in a new form 4 filed with the SEC $AXDX https://t.co/7dDKj1G8rX January 13th 2022, 4:01am |
|
@ResearchPool $AXDX #ACCELERATE DIAGNOSTICS INC ... InsiderInsights Daily Ratings Report: December 22, 2021: InsiderInsights Rati… https://t.co/hOhiUYEIgn January 13th 2022, 4:01am |
|
@ResearchPool $AXDX #ACCELERATE DIAGNOSTICS INC ... InsiderInsights Daily Ratings Report: December 21, 2021: InsiderInsights Rati… https://t.co/nZZWp0j1Jy January 13th 2022, 4:01am |
|
@ResearchPool $AXDX #ACCELERATE DIAGNOSTICS INC ... InsiderInsights Daily Ratings Report: December 20, 2021: InsiderInsights Rati… https://t.co/ngZOdmd5VN January 13th 2022, 4:01am |
|
@ResearchPool $AXDX #ACCELERATE DIAGNOSTICS INC ... InsiderInsights Weekly Tables: December 4, 2021: InsiderInsights Ratings of C… https://t.co/4Xnh5RDS2V January 13th 2022, 4:01am |
|
@ResearchPool $AXDX #ACCELERATE DIAGNOSTICS INC ... InsiderInsights Daily Ratings Report: November 30, 2021: InsiderInsights Rati… https://t.co/kvF5ivd7XP January 13th 2022, 4:01am |
|
@aistockfinder $AXDX https://t.co/JM2SBR7wQT Accelerate Diagnostics Inc. The current setup lets us believe the value of this compa… https://t.co/Jw70qC31an January 13th 2022, 12:01am |
 |
@Gambiste1 RT @invescent: $AXDX Data indicates that the overall analyst sentiment for AXDX is bullish. Simplify the way you research stocks with ou… January 12th 2022, 9:01pm |
 |
@invescent $AXDX Data indicates that the overall analyst sentiment for AXDX is bullish. Simplify the way you research stock… https://t.co/hfaI92kt3z January 12th 2022, 9:01pm |
|
@FlashAlert_me $AXDX [15s. delayed] filed SEC form 4: Director SCHULER JACK W: Acquired 45,226 of Common Stock at price $4.34 on… https://t.co/Aj9PqgRiBZ January 12th 2022, 9:01pm |
|
@newsfilterio Accelerate Diagnostics Wins Suzhou Innovation Award to Support Continued China Commercialization Efforts $AXDX https://t.co/0VXo1gOnFG January 12th 2022, 6:01pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?